Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Kidney International Reports|September 22, 2025
Dysregulated Anaerobic Glycolysis in Podocytes is Relevant to the Progression of Focal Segmental GlomerulosclerosisMasahiro Sugimura, Kayaho Maeda, Katsuaki Shibata, et al.
CEN Case Reports|April 28, 2026
Acute kidney injury with interstitial hemorrhage in renal heavy chain amyloidosis: a clinicopathologic case reportNozomi Mori, Kayaho Maeda, Rie Ito, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2015
CD147/basigin limits lupus nephritis and Th17 cell differentiation in mice by inhibiting the interleukin-6/STAT-3 pathwayKayaho Maeda, Tomoki Kosugi, Waichi Sato, et al.
The American Journal of Pathology|February 11, 2017
Growth Factor Midkine Promotes T-Cell Activation through Nuclear Factor of Activated T Cells Signaling and Th1 Cell Differentiation in Lupus NephritisTomohiro Masuda, Kayaho Maeda, Waichi Sato, et al.
The American Journal of Pathology|April 25, 2019
CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK SignalingTomoki Yoshioka, Tomoki Kosugi, Tomohiro Masuda, et al.
The American Journal of Pathology|December 4, 2012
Deficiency of growth factor midkine exacerbates necrotizing glomerular injuries in progressive glomerulonephritisHiroshi Kojima, Tomoki Kosugi, Waichi Sato, et al.
Internal Medicine (Tokyo, Japan)|February 9, 2025
Unexpected Hypotension in a Female Patient with Fabry Disease: Switching from Agalsidase α to β after Long-term ERTTakuya Sugiura, Reiko Muto, Tatsuaki Amano, et al.
JCI Insight|June 21, 2019
Pyruvate kinase M2 is requisite for Th1 and Th17 differentiationMichihito Kono, Kayaho Maeda, Irina Stocton-Gavanescu, et al.
Clinical and Experimental Nephrology|December 6, 2013
CD147/basigin reflects renal dysfunction in patients with acute kidney injuryHiroshi Nagaya, Tomoki Kosugi, Mayuko Maeda-Hori, et al.
Frontiers in Medicine|June 13, 2022
Protocol for a Phase 1, Open-Label, Multiple-Center, Dose-Escalation Study to Evaluate the Safety and Tolerability of ADR-001 in the Treatment of Immunoglobulin A NephropathyAkihito Tanaka, Kazuhiro Furuhashi, Kumiko Fujieda, et al.
Pageof 5